share_log

HC Wainwright & Co. Initiates Coverage On Structure Therapeutics With Buy Rating, Announces Price Target of $80

HC Wainwright & Co. Initiates Coverage On Structure Therapeutics With Buy Rating, Announces Price Target of $80

HC Wainwright & Co. 对Structure Therapeutics启动覆盖,给予买入评级,并宣布目标价为80美元。
Benzinga ·  12/04 19:30  · 评级/大行评级

HC Wainwright & Co. analyst Andrew Fein initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Buy rating and announces Price Target of $80.

HC韦恩赖特证券的分析师安德鲁·费恩开始对Structure Therapeutics (纳斯达克:GPCR) 进行覆盖,并给予买入评级,宣布目标价为80美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发